Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 3769 - 3776 of 11617 results
'Low-Hanging Fruit' and Other Recent HIPAA Compliance Items
May 1, 2020| News
COVID-19 and Poison Pills: The Right Prescription?
April 30, 2020| Advisory| Viewpoint
SEC Brings Action Against Company and its CEO for Alleged COVID-19 Scam
April 30, 2020| Blog| Viewpoint
FINRA Fines Broker-Dealer for Sharing Customer Data with Third-Party Vendor
April 30, 2020| Blog| Viewpoint
COVID-19 and Lab Testing: What’s the Story Behind the Story?
April 29, 2020| Blog| Viewpoint
Newest Version of Form I-9 Must Be Used Starting May 1, 2020. Updated M-274, Handbook for Employers Now Available
April 29, 2020| Blog| Viewpoint
Supreme Court Holds that States Cannot Copyright Annotated Versions of Their Statutes
April 29, 2020| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.